Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells—An Update

Over the last two decades, dendritic cell (DC) vaccination has been studied extensively as active immunotherapy in cancer treatment and has been proven safe in all clinical trials both with respect to short and long-term side effects. For antigen-loading of dendritic cells (DCs) one method is to int...

Descripción completa

Detalles Bibliográficos
Autores principales: Dörrie, Jan, Schaft, Niels, Schuler, Gerold, Schuler-Thurner, Beatrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076681/
https://www.ncbi.nlm.nih.gov/pubmed/31979205
http://dx.doi.org/10.3390/pharmaceutics12020092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076681/
https://www.ncbi.nlm.nih.gov/pubmed/31979205
http://dx.doi.org/10.3390/pharmaceutics12020092

Ejemplares similares